The experts for TLR agonists and antagonists. Innaxon develops and manufactures defined “Immunoceuticals” of the highest activity and purity for pre-clinical research and development applications for vaccine adjuvants and immuno-therapy. Their unique biological and synthetic toll-like receptor (TLR) ligands (IAXO compounds) are well-characterized and effective biological response modifiers of inappropriate or disproportionate immune responses.

Innaxon is a part of AdipoGen Life Sciences, who also cooperates with a number of other manufacturers such as: AbFrontier, Ancell CorporationBioActs, BioViotica, Chemodex, Chimerigen Laboratories, JaICA, South Bay Bio, and SYNkinase.

Major product lines

  • Immunoceuticals
For more information, Innaxon flyer and Innate Immunity brochure or visit Adipogen-Innaxon